There is no clinical trial data on the use of andexanet alfa in pregnancy, labor, delivery, or lactation. Safety has not had testing in patients who have experienced thrombosis or disseminated intravascular coagulation within 14 days before bleeding, requiring andexanet alfa treatment. It has also not been the subject of testing in patients who received prothrombin complex concentrates, recombinant factor VIIa, or whole blood products within seven days before bleeding requiring andexanet alfa treatment.